Literature DB >> 4364176

Metabolism of penicillins to penicilloic acids and 6-aminopenicillanic acid in man and its significance in assessing penicillin absorption.

M Cole, M D Kenig, V A Hewitt.   

Abstract

Penicillins can be metabolized to penicilloic acids in man, the extent being dependent on the penicillin structure. In the phenoxy penicillin series, phenoxymethyl penicillin was found to be particularly unstable, but the higher homologues were more stable. In the isoxazolyl series, oxacillin was unstable, and progressive insertion of halogen in the phenyl ring increased stability. Ampicillin and amoxycillin showed some instability, ampicillin possibly being the more stable. After intramuscular administration, carbenicillin was very stable in the body, ampicillin was fairly stable, and benzyl penicillin was unstable. It is important to take into account the penicilloic acid content of urine when estimating total absorption of a penicillin. Increased stability in the body as well as slower renal clearance can lead to high concentrations in the serum. Penicilloic acids seemed to be more slowly cleared from the body than penicillins. The liver is probably the site of inactivation.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4364176      PMCID: PMC444435          DOI: 10.1128/AAC.3.4.463

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  6-Aminopenicillanic acid in urine after oral administration of penicillins.

Authors:  A R ENGLISH; H T HUANT; B A SOBIN
Journal:  Proc Soc Exp Biol Med       Date:  1960-07

2.  Colorimetric detection of penicillins and cephalosporins on paper.

Authors:  R THOMAS
Journal:  Nature       Date:  1961-09-16       Impact factor: 49.962

3.  Inactivation of penicillins by the isolated rat liver.

Authors:  A C Kind; H N Beaty; L F Fenster; W M Kirby
Journal:  J Lab Clin Med       Date:  1968-05

4.  Mechanisms responsible for the blood level differences of isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.

Authors:  J E Rosenblatt; A C Kind; J L Brodie; W M Kirby
Journal:  Arch Intern Med       Date:  1968-04

5.  The role of penicillin acylase in the resistance of gram-negative bacteria to penicillins.

Authors:  M Cole; R Sutherland
Journal:  J Gen Microbiol       Date:  1966-03

6.  Clinical pharmacology of carbenicillin compared with other penicillins.

Authors:  H C Standiford; M C Jordan; W M Kirby
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

7.  Amoxycillin: a new semi-synthetic penicillin.

Authors:  R Sutherland; E A Croydon; G N Rolinson
Journal:  Br Med J       Date:  1972-07-01

8.  -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.

Authors:  R Sutherland; J Burnett; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

9.  Determination of phenoxymethyl penicilloic acid and phenoxyethyl penicilloic acid in urine in the presence of the parent penicillins.

Authors:  J Birner
Journal:  J Pharm Sci       Date:  1970-06       Impact factor: 3.534

  9 in total
  37 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  BRL.8988 (talampicillin), a well-absorbed oral form of ampicillin.

Authors:  J P Clayton; M Cole; S W Elson; H Ferres
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

4.  Absorption of amino penicillins from everted rat intestine.

Authors:  C Dixon; L W Mizen
Journal:  J Physiol       Date:  1977-08       Impact factor: 5.182

5.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.

Authors:  Charles R Evans; Alla Karnovsky; Melissa A Kovach; Theodore J Standiford; Charles F Burant; Kathleen A Stringer
Journal:  J Proteome Res       Date:  2013-12-09       Impact factor: 4.466

7.  Active metabolites of isoxazolylpencillins in humans.

Authors:  H H Thijssen; H Mattie
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

8.  In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin.

Authors:  Carlos A Rodriguez; Maria Agudelo; Andres F Zuluaga; Omar Vesga
Journal:  BMC Infect Dis       Date:  2010-06-04       Impact factor: 3.090

9.  The pharmacokinetics of furazlocillin in healthy humans.

Authors:  P H Hinderling; U Gundert-Remy; D Förster; W Gau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

10.  The metabolic disposition of flucloxacillin in patients with impaired kidney function.

Authors:  H H Thijssen; J Wolters
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.